Literature DB >> 9585934

The metalloprotease inhibitor 1,10-phenanthroline affects Schistosoma mansoni motor activity, egg laying and viability.

T A Day1, G Z Chen.   

Abstract

The Zn(2+)-chelating metalloprotease inhibitor 1,10-phenanthroline (phenanthroline, 5-150 microM) elicited dose-dependent contraction of the longitudinal and circular (transverse) musculature of adult male schistosomes. At the same concentrations, phenanthroline did not cause contraction of dispersed individual muscle fibres. The phenanthroline-induced contractions were reduced by the inclusion of 100 or 300 microM Zn2+ in the extracellular medium. Phenanthroline (0.5-150 microM) also inhibited the egg production of adult worm pairs in vitro, with a 98% reduction at 50 microM. When worm pairs were exposed to phenanthroline, the males detached from the dish and released the females, resulting in unpaired worms. At the higher concentrations (50 and 150 microM), the worms were killed in vitro. Worm burdens were reduced by over 50% in infected mice injected with phenanthroline (20 mg/kg/day for 4 days), but twice the dose resulted in only a 25% reduction. Phenanthroline injections also induced an hepatic shift and an unpairing of adult worms in infected mice, and the female worms appeared degenerate and lacked gut pigmentation. Mice fed a diet containing 0.3% phenanthroline received significant protection from infection when challenged with schistosome cercaria, where phenanthroline-fed mice had 94% fewer adult worms than control mice. The broad range of phenanthroline effects on schistosomes suggests broad and important functions for metalloproteases in these worms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585934     DOI: 10.1017/s0031182097002370

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  7 in total

1.  Phenantroline, lovastatin, and mebendazole do not inhibit oviposition in the murine experimental infection with Angiostrongylus costaricensis.

Authors:  Márcia Bohrer Mentz; Eliane Dallegrave; Aventino Agostini; Carlos Graeff-Teixeira
Journal:  Parasitol Res       Date:  2006-08-30       Impact factor: 2.289

2.  Alternative Enzyme Protection Assay To Overcome the Drawbacks of the Gentamicin Protection Assay for Measuring Entry and Intracellular Survival of Staphylococci.

Authors:  Jin-Hahn Kim; Akhilesh Kumar Chaurasia; Nayab Batool; Kwan Soo Ko; Kyeong Kyu Kim
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

3.  Leishmania major degrades murine CXCL1 - An immune evasion strategy.

Authors:  Matthew S Yorek; Barun Poudel; Lalita Mazgaeen; R Marshall Pope; Mary E Wilson; Prajwal Gurung
Journal:  PLoS Negl Trop Dis       Date:  2019-07-01

4.  Proteases secreted by Trichinella spiralis intestinal infective larvae damage the junctions of the intestinal epithelial cell monolayer and mediate larval invasion.

Authors:  Yan Yan Song; Qi Qi Lu; Lu Lu Han; Shu Wei Yan; Xin Zhuo Zhang; Ruo Dan Liu; Shao Rong Long; Jing Cui; Zhong Quan Wang
Journal:  Vet Res       Date:  2022-03-07       Impact factor: 3.683

5.  Analysis of regulatory protease sequences identified through bioinformatic data mining of the Schistosoma mansoni genome.

Authors:  David H Bos; Chris Mayfield; Dennis J Minchella
Journal:  BMC Genomics       Date:  2009-10-21       Impact factor: 3.969

6.  Genome-wide analysis of regulatory proteases sequences identified through bioinformatics data mining in Taenia solium.

Authors:  Hong-Bin Yan; Zhong-Zi Lou; Li Li; Paul J Brindley; Yadong Zheng; Xuenong Luo; Junling Hou; Aijiang Guo; Wan-Zhong Jia; Xuepeng Cai
Journal:  BMC Genomics       Date:  2014-06-04       Impact factor: 3.969

7.  A metalloprotease produced by larval Schistosoma mansoni facilitates infection establishment and maintenance in the snail host by interfering with immune cell function.

Authors:  Jacob R Hambrook; Alèthe L Kaboré; Emmanuel A Pila; Patrick C Hanington
Journal:  PLoS Pathog       Date:  2018-10-29       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.